Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years
Ocugen’s partner Bharat Biotech’s phase-II/III study of Covaxin (BBV152) in 526 children showed safety, efficacy, and superior…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ocugen
US FDA lifts hold on Covaxin’s clinical trials
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
Bharat Biotech and Ocugen committed to bring Covaxin in US and Canada
On 4th March, Ocugen Inc had announced that the US FDA has declined to issue a EUA for Covaxin for active immunisation to prevent…
FDA declines paediatric EUA for Ocugen’s Covaxin
Ocugen had entered into a deal with vaccine maker Bharat Biotech in late 2020, under which it would develop, supply and…
Covaxin to be evaluated as COVID-19 vaccine candidate in US as US FDA lifts clinical hold
Ocugen Inc is co-developing the Covaxin vaccine candidate for COVID-19 in the US and Canada
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials
The development comes a day after the World Health Organization (WHO) sought more details from Bharat Biotech to consider its…
Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…
Jubilant HollisterStier partners with Ocugen to make Covaxin for US, Canadian markets
Jubilant HollisterStier has manufacturing units in Spokane (US) and Montreal (Canada)
Ocugen to apply for full US FDA approval of Covaxin, not for EUA
Ocugen said the decision was based on a recommendation from the US FDA, which also requested more information and data for full…
Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada
Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada